Avidity Partners Management’s Ortho Clinical Diagnostics Holdings OCDX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCDX
Avidity Partners Management's OCDX Position: Q1 2022 in Review
Avidity Partners Management sold out of Ortho Clinical Diagnostics Holdings (OCDX) in Q1 2022, closing a stake of 1,790,000 shares — an estimated $38.3M sold.
Avidity Partners Management first reported a position in OCDX in Q3 2021 and held it in 2 quarters. The position peaked at $44.3M in Q3 2021. 169 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.
- Avidity Partners Management reported no remaining Ortho Clinical Diagnostics Holdings position as of Q1 2022 after selling out during the quarter.
- Avidity Partners Management sold 1,790,000 Ortho Clinical Diagnostics Holdings shares in Q1 2022, an estimated $38.3M.
- Avidity Partners Management first reported a position in Ortho Clinical Diagnostics Holdings in Q3 2021 and held it in 2 quarters.
- Avidity Partners Management's Ortho Clinical Diagnostics Holdings position peaked at $44.3M in Q3 2021.
- 169 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings as of Q1 2022.
Based on Avidity Partners Management's 13F filing for Q1 2022, filed 16 May 2022.